Crossmark

Increased risk of anaphylaxis following administration of 2009 AS03-adjuvanted monovalent pandemic A/H1N1 (H1N1pdm09) vaccine

Crossref DOI link: https://doi.org/10.1016/j.vaccine.2013.10.033

Published Print: 2013-12

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Rouleau, Isabelle

De Serres, Gaston

Drolet, Jean Philippe

Skowronski, Danuta M.

Ouakki, Manale

Toth, Eveline

Landry, Monique

Ménard, Suzanne

Gagnon, Rémi
License Information

Text and Data Mining valid from 2013-12-01
More Information

This article is maintained by: Elsevier

Article Title: Increased risk of anaphylaxis following administration of 2009 AS03-adjuvanted monovalent pandemic A/H1N1 (H1N1pdm09) vaccine

Journal Title: Vaccine

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.vaccine.2013.10.033

Content Type: article

Copyright: Copyright © 2013 Elsevier Ltd. All rights reserved.